Cargando...
Generalization and representativeness of phase III immune checkpoint blockade trials in non‐small cell lung cancer
BACKGROUND: Strict eligibility criteria for patient enrollment in phase III trials raise questions regarding generalization to ineligible patients. We evaluated whether pivotal phase III trials of immune checkpoint blockades (ICBs) represent the overall population of non‐small cell lung cancer (NSCL...
Guardado en:
| Publicado en: | Thorac Cancer |
|---|---|
| Autores principales: | , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
John Wiley & Sons Australia, Ltd
2018
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6456815/ https://ncbi.nlm.nih.gov/pubmed/29682899 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.12641 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|